Clearstead Advisors’s Integra LifeSciences IART Stock Holding History

Clearstead Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.97K	Buy	+221	New	+$3.09K	﹤0.01%	2260
2025 Q4	–	Sell	-299	Closed	-$4.29K	–	2975
2025 Q3	$4.29K	Buy	299 +214	+252%	+$2.93K	﹤0.01%	2213
2025 Q2	$1.04K	Buy	+85	New	+$1.23K	﹤0.01%	2426
2024 Q3	–	Sell	-356	Closed	-$10.4K	–	2072
2024 Q2	$10.4K	Buy	+356	New	+$10.6K	﹤0.01%	1544
2021 Q4	–	Sell	-300	Closed	-$21K	–	1350
2021 Q3	$21K	Buy	+300	New	+$21.2K	﹤0.01%	800

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Clearstead Advisors's IART Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Integra LifeSciences (IART) in Q2 2026: 221 shares worth $3.97K. The stake represents ﹤0.01% of the portfolio and ranks #2260 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in IART as recently as Q3 2025.

Clearstead Advisors first reported a position in IART in Q3 2021 and has held it in 5 quarters since. The position peaked at $21K in Q3 2021. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Clearstead Advisors held 221 shares of Integra LifeSciences worth $3.97K as of Q2 2026.
Integra LifeSciences was a new Clearstead Advisors position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2260 holding.
Clearstead Advisors first reported a position in Integra LifeSciences in Q3 2021 and has held it in 5 quarters since.
Clearstead Advisors's Integra LifeSciences position peaked at $21K in Q3 2021.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.